Essentials of Perinatal Hepatitis B Prevention 2008

Essentials of Perinatal Hepatitis B Prevention 2008
Session Three: Evaluation

(Scroll down to start the program)

Continuing Education (CE) credits for these sessions has expired.

This information was updated on June 1, 2009
Release Date: May 28, 2008
The information on this webcast is certified for credit until March 19, 2011
Continuing Education credit for this program expires on March 19, 2011.

Immunization recommendations change frequently. You are strongly encouraged to visit the CDC Vaccines and Immunization website for updates of this program at

This program will provide up-to-date information for program manages and case manager of perinatal hepatitis B prevention programs. Four sessions are available in this training series:
SESSION One: Case Identification
SESSION Two: Case Management
SESSION Three: Assessment and Evaluation
SESSION Four: Hospital as Safety Net

Learning Objectives
After completing this training the participant will be able to:
Describe key components of evaluation of a perinatal hepatitis B prevention program.

The running time of this program is 1 hour 15 minutes.

Healthcare providers and administrators who work or are interested in perinatal hepatitis B prevention. This includes physicians, nurses, pharmacists, health educators. Most specifically, this program is targeted to program managers and case managers working in perinatal hepatitis B prevention program.

Use of trade names or commercial sources is for informational purposes only and does not constitute an endorsement by the United States Department of Health and Human Services or the Public Health Service.

Views expressed by guest participants are not necessarily the views of the Centers for Disease Control and Prevention.

CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.

Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.

There are no commercial supporters.

The content experts for this program are from the Centers for Disease Control and Prevention.

Lisa Jacques-Carroll BSW, MSW, Public Health Advisor, CDC, NCRID
Patricia Hoskins-Saffold, RN, MSN, Perinatal Hepatitis B Coordinator, Chicago Department of Public Health


This activity is delivered as a streamed video via the Internet.
To view this program the following equipment is needed:
A computer equipped with an internet connection and software that is compatible with Windows Media® media player.

Learners can provide feedback and ask questions about this program’s content through email inquiries sent to

This program was funded and produced by the Centers for Disease Control and Prevention in Atlanta, Georgia, USA. There are no commercial supporters.

Transcripts and handouts to accompany this program are available at